-
Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA. Immunoglobulin light chain amyloidosis. Expert Rev Hematol. 2014 Feb; 7(1):143-56. PMID: 24350907; DOI: 10.1586/17474086.2014.858594;
-
Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9.View Related Profiles. PMID: 24317129; DOI: 10.1038/bmt.2013.192;
-
Gray Gilstrap L, Niehaus E, Malhotra R, Ton VK, Watts J, Seldin DC, Madsen JC, Semigran MJ. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis. J Heart Lung Transplant. 2014 Feb; 33(2):149-56. PMID: 24200511; PMCID: PMC3946702; DOI: 10.1016/j.healun.2013.09.004;
-
Leung A, Nah SK, Reid W, Ebata A, Koch CM, Monti S, Genereux JC, Wiseman RL, Wolozin B, Connors LH, Berk JL, Seldin DC, Mostoslavsky G, Kotton DN, Murphy GJ. Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports. 2013; 1(5):451-63.View Related Profiles. PMID: 24286032; PMCID: PMC3841264; DOI: 10.1016/j.stemcr.2013.10.003;
-
Guan J, Mishra S, Shi J, Plovie E, Qiu Y, Cao X, Gianni D, Jiang B, Del Monte F, Connors LH, Seldin DC, Lavatelli F, Rognoni P, Palladini G, Merlini G, Falk RH, Semigran MJ, Dec GW, Macrae CA, Liao R. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol. 2013 Sep; 108(5):378.View Related Profiles. PMID: 23982491; PMCID: PMC3914405; DOI: 10.1007/s00395-013-0378-5;
-
Sanchorawala V, Hoering A, Seldin DC, Finn KT, Fennessey SA, Sexton R, Mattar B, Safah HF, Holmberg LA, Dean RM, Orlowski RZ, Barlogie B. Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115. Bone Marrow Transplant. 2013 Nov; 48(12):1537-42.View Related Profiles. PMID: 23852321; PMCID: PMC3855173; DOI: 10.1038/bmt.2013.98;
-
Girnius S, Seldin DC, Cibeira MT, Sanchorawala V. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation. J Clin Oncol. 2013 Jul 20; 31(21):2749-50.View Related Profiles. PMID: 23775968; DOI: 10.1200/JCO.2013.48.7736;
-
Sanchorawala V, Shelton AC, Zeldis JB, Seldin DC. Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide. Am J Hematol. 2013 Aug; 88(8):719.View Related Profiles. PMID: 23650113; DOI: 10.1002/ajh.23470;
-
Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, MacRae CA, Liao R. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol. 2013 Jul 1; 305(1):H95-103.View Related Profiles. PMID: 23624626; PMCID: PMC3727100; DOI: 10.1152/ajpheart.00186.2013;
-
-
-
Taimur S, Nader C, Lloyd-Travaglini C, Seldin DC, Sanchorawala V. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis. Transpl Infect Dis. 2013 Apr; 15(2):187-94.View Related Profiles. PMID: 23279695; DOI: 10.1111/tid.12037;
-
Shin JT, Ward JE, Collins PA, Dai M, Semigran HL, Semigran MJ, Seldin DC. Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report. Amyloid. 2012 Dec; 19(4):191-6.View Related Profiles. PMID: 23126591; DOI: 10.3109/13506129.2012.733741;
-
Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6.View Related Profiles. PMID: 23175664; DOI: 10.1182/blood-2012-09-457341;
-
-
Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE. Epithelial-to-mesenchymal transition induced by TGF-ß1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res. 2012 Dec 1; 72(23):6268-78.View Related Profiles. PMID: 23054396; PMCID: PMC3513653; DOI: 10.1158/0008-5472.CAN-12-2270;
-
Shi X, Seldin DC, Garry DJ. Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. Biochem J. 2012 Sep 15; 446(3):349-57. PMID: 22716292; DOI: 10.1042/BJ20120563;
-
Rosenzweig MA, Landau H, Seldin D, O'Hara C, Girnius S, Hanson N, Frosina D, Sedrak C, Arcila M, Comenzo RL, Giralt S, Gnjatic S, Jungbluth AA, Koehne G. Cancer-testis antigen expression and immunogenicity in AL amyloidosis. Blood Cancer J. 2012; 2:e90.View Related Profiles. PMID: 22983433; PMCID: PMC3461704; DOI: 10.1038/bcj.2012.32;
-
Girnius S, Skinner M, Spencer B, Prokaeva T, Bartholomew C, O'Hara C, Seldin DC, Connors LH. A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid. 2012 Dec; 19(4):182-5.View Related Profiles. PMID: 22978355; DOI: 10.3109/13506129.2012.723074;
-
-
Cowan AJ, Seldin DC, Skinner M, Quillen K, Doros G, Tan J, O'Hara C, Finn KT, Sanchorawala V. Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1935-8.View Related Profiles. PMID: 22842332; PMCID: PMC4161277; DOI: 10.1016/j.bbmt.2012.07.016;
-
-
Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. Amyloid. 2012 Sep; 19(3):156-60.View Related Profiles. PMID: 22680044; DOI: 10.3109/13506129.2012.694825;
-
Comenzo RL, Reece D, Palladini G, Seldin D, Sanchorawala V, Landau H, Falk R, Wells K, Solomon A, Wechalekar A, Zonder J, Dispenzieri A, Gertz M, Streicher H, Skinner M, Kyle RA, Merlini G. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 2012 Nov; 26(11):2317-25.View Related Profiles. PMID: 22475872; DOI: 10.1038/leu.2012.100;
-
-
Sanchorawala V, Seldin DC. AL amyloidosis: who, what, when, why, and where. Oncology (Williston Park). 2012 Feb; 26(2):164, 166, 169.View Related Profiles. PMID: 22489350
-
Ward JE, Ren R, Toraldo G, Soohoo P, Guan J, O'Hara C, Jasuja R, Trinkaus-Randall V, Liao R, Connors LH, Seldin DC. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood. 2011 Dec 15; 118(25):6610-7.View Related Profiles. PMID: 21998211; PMCID: PMC3242721; DOI: 10.1182/blood-2011-04-351643;
-
Flies A, Ahmadi T, Parks AJ, Prokaeva T, Weng L, Rolfe SS, Seldin DC, Sherr DH. Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis. Immunol Cell Biol. 2012 May; 90(5):528-39.View Related Profiles. PMID: 21894172; DOI: 10.1038/icb.2011.73;
-
-
-
Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52.View Related Profiles. PMID: 21828140; PMCID: PMC3204906; DOI: 10.1182/blood-2011-01-330738;
-
-
-
-
Meier-Ewert HK, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Ruberg FL. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Amyloid. 2011 Jun; 18 Suppl 1:130-1.View Related Profiles. PMID: 21838460; DOI: 10.3109/13506129.2011.574354048;
-
-
Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9.View Related Profiles. PMID: 21838459; PMCID: PMC5601311; DOI: 10.3109/13506129.2011.574354047;
-
-
-
Tsai SB, Seldin DC, Wu H, O'Hara C, Ruberg FL, Sanchorawala V. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid. 2011 Sep; 18(3):160-4.View Related Profiles. PMID: 21504342; DOI: 10.3109/13506129.2011.571319;
-
-
-
-
Seldin DC, Skinner M . Amyloidosis. Chapter 116. in: GS Firestein, RC Budd, ED Harris, IB McInnes, S Ruddy, and JS Sergent, ed. Kelley's Textbook of Rheumatology 9th edition. Elsevier. Philadelphia,PA. 2011.
-
Seldin DC, Skinner M. Amyloidosis. Chapter 324. in: D Longo, A Fauci, D Kasper, S Hauser, J Jameson, and J Loscalzo ed. Harrison's Principles of Internal Medicine 18th Edition. McGraw-Hill. NJ. 2011.
-
-
Tapan U, Seldin DC, Finn KT, Fennessey S, Shelton A, Zeldis JB, Sanchorawala V. Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis. Blood. 2010 Dec 2; 116(23):5071-2.View Related Profiles. PMID: 21127185; DOI: 10.1182/blood-2010-09-305136;
-
-
Dey BR, Chung SS, Spitzer TR, Zheng H, Macgillivray TE, Seldin DC, McAfee S, Ballen K, Attar E, Wang T, Shin J, Newton-Cheh C, Moore S, Sanchorawala V, Skinner M, Madsen JC, Semigran MJ. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure. Transplantation. 2010 Oct 27; 90(8):905-11.View Related Profiles. PMID: 20733534; PMCID: PMC2964067; DOI: 10.1097/TP.0b013e3181f10edb;
-
Klimtchuk ES, Gursky O, Patel RS, Laporte KL, Connors LH, Skinner M, Seldin DC. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry. 2010 Nov 16; 49(45):9848-57.View Related Profiles. PMID: 20936823; PMCID: PMC4080313; DOI: 10.1021/bi101351c;
-
Quillen K, Seldin DC, Finn KT, Sanchorawala V. A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis. Bone Marrow Transplant. 2011 Jul; 46(7):976-80.View Related Profiles. PMID: 20956955; DOI: 10.1038/bmt.2010.239;
-
Ren R, Hong Z, Gong H, Laporte K, Skinner M, Seldin DC, Costello CE, Connors LH, Trinkaus-Randall V. Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils. J Biol Chem. 2010 Nov 26; 285(48):37672-82.View Related Profiles. PMID: 20870723; PMCID: PMC2988372; DOI: 10.1074/jbc.M110.149575;
-
-
Shahid M, Shen L, Seldin DC, Lu B, Ustyugova IV, Chen X, Zapol WM, Wu MX. Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cells. Hypertension. 2010 Oct; 56(4):705-12. PMID: 20713914; PMCID: PMC3157252; DOI: 10.1161/HYPERTENSIONAHA.110.154880;
-
Specter R, Sanchorawala V, Seldin DC, Shelton A, Fennessey S, Finn KT, Zeldis JB, Dember LM. Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrol Dial Transplant. 2011 Mar; 26(3):881-6.View Related Profiles. PMID: 20693160; PMCID: PMC3108346; DOI: 10.1093/ndt/gfq482;
-
Girnius S, Seldin DC, Quillen K, Dember LM, Segal A, Sanchorawala V. Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation. Bone Marrow Transplant. 2011 Jan; 46(1):161-2.View Related Profiles. PMID: 20383204; DOI: 10.1038/bmt.2010.82;
-
-
Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A. 2010 Mar 2; 107(9):4188-93.View Related Profiles. PMID: 20150510; PMCID: PMC2840082; DOI: 10.1073/pnas.0912263107;
-
Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Ann Hematol. 2010 Jun; 89(6):579-84.View Related Profiles. PMID: 20012043; DOI: 10.1007/s00277-009-0874-8;
-
Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J. 2009 Oct; 158(4):607-14.View Related Profiles. PMID: 19781421; DOI: 10.1016/j.ahj.2009.08.006;
-
-
-
Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica. 2009 Jul; 94(7):1029-32.View Related Profiles. PMID: 19454500; PMCID: PMC2704317; DOI: 10.3324/haematol.2008.001925;
-
Rosenzweig M, Seldin DC, Remick DG, Skinner M, Quillen K, Oran B, Finn KT, Sanchorawala V. Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction. Bone Marrow Transplant. 2010 Jan; 45(1):21-4.View Related Profiles. PMID: 19421171; PMCID: PMC3672063; DOI: 10.1038/bmt.2009.94;
-
Near RI, Smith RS, Toselli PA, Freddo TF, Bloom AB, Vanden Borre P, Seldin DC, Lerner A. Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens. Mol Vis. 2009; 15:685-99.View Related Profiles. PMID: 19365570; PMCID: PMC2666772
-
-
Tam M, Seldin DC, Forbes BM, Connors LH, Skinner M, Oran B, Quillen K, Sanchorawala V. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Amyloid. 2009; 16(2):103-7.View Related Profiles. PMID: 20536404; PMCID: PMC2911629; DOI: 10.1080/13506120902879574;
-
Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Seldin DS, Sam F. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ Heart Fail. 2008 Nov; 1(4):249-57.View Related Profiles. PMID: 19808299; PMCID: PMC2774449; DOI: 10.1161/CIRCHEARTFAILURE.108.788687;
-
Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol. 2008 Oct; 10(10):1208-16.View Related Profiles. PMID: 18806787; PMCID: PMC2830866; DOI: 10.1038/ncb1781;
-
-
Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Théberge R, Connors LH, Bellotti V, Seldin DC, Merlini G, Skinner M, Costello CE. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics. 2008 Aug; 7(8):1570-83.View Related Profiles. PMID: 18474516; PMCID: PMC2494907; DOI: 10.1074/mcp.M700545-MCP200;
-
Prokaeva T, Spencer B, Doros G, Eberhard J, Jiang Y, Budnik M, Theberge R, Costello CE, Connors LH, Skinner M, Seldin DC. Somatic mutations create potential N-glycosylation sites in the immunoglobulin light chain variable regions (VL) in primary amyloidosis (AL). Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton. 2008; 292-294.
-
Connors LH, Eberhard J, Spencer B, Prokaeva T, Jiang Y, Budnik M, Theberge R, Seldin, DC, Costello CE, Skinner M. Comparison of immunoglobulin light chains (kappa 1): amyloidogenic vs. non-amyloidogenic proteins. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton. 2008; 240-242.
-
Seldin DC and Skinner M. Amyloidosis. Chapter 116. in: GS Firestein, RC Budd, ED Harris, IB McInnes, S Ruddy, and JS Sergent, ed. Kelley's Textbook of Rheumatology 8th edition. Elsevier. Philadelphia,PA. 2008.
-
Ward JE, Brenner D, SooHoo P, Cui L, Liao R, Peng X, Sawyer D, Connors LH, Christiansen T, O'Hara C, Skinner M, Seldin DC . Mouse Models of AL Amyloidosis. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton,FL. 2008; 321-323.
-
Seldin, DC . Keynote Address: Can Amyloidosis Be Cured?. In Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton,FL. 2008; 219-221.
-
Skinner M, Berk JL, Connors LH, Seldin DC. ed. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis. Taylor & Francis. Boca Raton. 2008.
-
Theberge R, Jiang Y, McComb ME, Prokaeva T, Connors LH, Skinner M, Seldin DC, Costello CE. . Detection and Characterization of Immunoglobulin Light Chain Posttranslational Modifications using LCMS-MS/MS. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton. 2008; 368-370.
-
Rosenzweig M, Sawyer D, Ruberg F, Wright D, Sanchorawala V, Seldin D, Vita J, Skinner M. A Trial of Antioxidants to Improve Cardiac Function in Patients with (AL) Amyloidosis and Cardiac Involvement. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton. 2008; 295-297.
-
Bodi K, Kaut M, Spencer B, Prokaeva T, Connors LH, Skinner M, Seldin DC. ALBase: a platform analysis tool for the study of amyloid light chains. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. . Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. ALBase: a platform analysis tool for the study of amyloid light chains. Taylor & Francis. Boca Raton. 2008; 231-233.
-
Lavatelli F, Perlman DH, McComb ME, Theberge R, Seldin DC, Connors LH, Merlini G, Skinner M, Costello CE. A proteomic approach to the study of systemic amyloidoses. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton. 2008; 360-362.
-
Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk J, Skinner M, Seldin DC. Treatment of AL Amyloidosis with Tandem Cycles of High Dose Melphalan and Autologous Stem Cell Transplantation: Final Analysis of a Prospective Trial. Proceedings of the XIth International Symposium on Amyloid and Amyloidosis, Skinner M, Berk JL, Connors LH, Seldin DC, ed. Taylor & Francis. Boca Raton. 2008; 393-395.
-
Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res. 2007 Dec 15; 67(24):11742-50.View Related Profiles. PMID: 18089804
-
Sanchorawala V, Seldin DC. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Amyloid. 2007 Dec; 14(4):261-9.View Related Profiles. PMID: 17968685
-
Connors LH, Jiang Y, Budnik M, Théberge R, Prokaeva T, Bodi KL, Seldin DC, Costello CE, Skinner M. Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry. 2007 Dec 11; 46(49):14259-71.View Related Profiles. PMID: 18004879; PMCID: PMC2912213; DOI: 10.1021/bi7013773;
-
Prokaeva T, Spencer B, Kaut M, Ozonoff A, Doros G, Connors LH, Skinner M, Seldin DC. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum. 2007 Nov; 56(11):3858-68.View Related Profiles. PMID: 17968927
-
-
-
Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk JL, Doros G, Fisher C, Skinner M, Seldin DC. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis. Bone Marrow Transplant. 2007 Sep; 40(6):557-62.View Related Profiles. PMID: 17589534
-
Kos CA, Ward JE, Malek K, Sanchorawala V, Wright DG, O'Hara C, Connors L, Skinner M, Seldin DC. Association of acquired von Willebrand syndrome with AL amyloidosis. Am J Hematol. 2007 May; 82(5):363-7.View Related Profiles. PMID: 17205535
-
Seldin DC, Skinner M. Amyloidosis. Chapter 324. in: DL Kasper, E Braunwald, A Fauci, S Hauser, DJL Jameson ed. Harrison's Principles of Internal Medicine 17th Edition. McGraw-Hill. NJ. 2007.
-
-
Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC. Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood. 2007 Jan 15; 109(2):492-6.View Related Profiles. PMID: 16960148
-
Sanchorawala V, Blanchard E, Seldin DC, O'Hara C, Skinner M, Wright DG. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol. 2006 Sep; 81(9):692-5.View Related Profiles. PMID: 16795060
-
Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem. 2006 Sep; 387(9):1175-87.View Related Profiles. PMID: 16972784
-
Seldin DC, Anderson JJ, Skinner M, Malek K, Wright DG, Quillen K, Finn K, Oran B, Sanchorawala V. Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65. Blood. 2006 Dec 1; 108(12):3945-7.View Related Profiles. PMID: 16926284; PMCID: PMC1895463; DOI: 10.1182/blood-2006-06-029728;
-
Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant. 2006 Sep; 38(5):339-43.View Related Profiles. PMID: 16862166
-
Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest. 2006 Jul; 116(7):1913-23.View Related Profiles. PMID: 16823489; PMCID: PMC1483170; DOI: 10.1172/JCI27933;
-
Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res. 2005 Dec 15; 65(24):11375-83.View Related Profiles. PMID: 16357145
-
Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid. 2005 Dec; 12(4):210-5.View Related Profiles. PMID: 16399645
-
Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol. 2005 Nov; 25(22):10136-47.View Related Profiles. PMID: 16260626; PMCID: PMC1280249; DOI: 10.1128/MCB.25.22.10136-10147.2005;
-
Sanchorawala V, Seldin DC, Magnani B, Skinner M, Wright DG. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplant. 2005 Oct; 36(7):597-600.View Related Profiles. PMID: 16044137
-
Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 2005 Jul 1; 65(13):5792-801.View Related Profiles. PMID: 15994955
-
Dominguez I, Mizuno J, Wu H, Imbrie GA, Symes K, Seldin DC. A role for CK2alpha/beta in Xenopus early embryonic development. Mol Cell Biochem. 2005 Jun; 274(1-2):125-31.View Related Profiles. PMID: 16342412
-
Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem. 2005 Jun; 274(1-2):63-7.View Related Profiles. PMID: 16342409
-
Oran B, Malek K, Sanchorawala V, Wright DG, Quillen K, Finn KT, La Valley M, Skinner M, Seldin DC. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2005 Mar; 35(6):567-75.View Related Profiles. PMID: 15665842
-
Ward JE, Brenner DA, Eberhard J, Liao R, Connors LH, O’Hara C, Seldin DC . In vitro and in vivo mouse models for AL amyloidosis. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner. CRC Press. Boca Raton,FL. 2005; 64-66.
-
Prokaeva T, Ward JE, Fingar E, Kaut M, Smith P, O’Hara C, Connors LH, Skinner M, Seldin DC . Immunoglobulin (IG) light chain (LC) variable (VL) region genes demonstrate evidence for antigen selection in primary amyloidosis (AL). In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner. CRC Press. Boca Raton. 2005; 43-45.
-
Jacobson D, Seldin DC, Buxbaum J. Chapter 101, Amyloidosis. In: Lichtman MA, Beutler E, Kaushansky K, Kipps TJ, Seligsohn U, and Prchal J, ed. Williams Hematology 7th Edition. McGraw-Hill. New York,NY. 2005.
-
Seldin DC, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Falk RH, Berk JL, Dember LM, Wiesman J, Anderson J, Skinner M . High dose melphalan and autologous stem cell transplantation (HDM/SCT) for treatment of AL amyloidosis: ten year single institutional experience. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner. CRC Press. Boca Raton,FL. 2005; 160-162.
-
Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, Sherr DH, Seldin DC. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol. 2005; 33(6):726-37.View Related Profiles. PMID: 16263698
-
Sanchorawala V, Wright DG, Quillen K, Kunz R, Finn KT, Malek K, Falk RH, Berk JL, Dember LM, Skinner M, Seldin DC . Treatment of AL amyloidosis with tandem cycles of high dose melphalan and autologous stem cell transplantation. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner. CRC Press. Boca Raton. 2005; 124-126.
-
Seldin DC, Skinner M . Amyloidosis. In: ED Harris, S Ruddy, CB Sledge, JS Sergent, and RC Budd, ed. Kelley's Textbook of Rheumatology 7th edition. Elsevier. Philadelphia,PA. 2005; 1697-1704.
-
Sipe JD, Seldin DC. Xth International Symposium on Amyloid and Amyloidosis April 18-22, 2004 (selected highlights) Tours, Loire Valley, France. Amyloid. 2004 Dec; 11(4):268-72. PMID: 15678763
-
Dominguez I, Mizuno J, Wu H, Song DH, Symes K, Seldin DC. Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. Dev Biol. 2004 Oct 1; 274(1):110-24.View Related Profiles. PMID: 15355792
-
Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004 Sep 15; 104(6):1888-93.View Related Profiles. PMID: 15155460
-
Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant. 2004 Feb; 33(4):381-8.View Related Profiles. PMID: 14676787
-
Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004 Jan 20; 140(2):85-93.View Related Profiles. PMID: 14734330
-
Seldin DC. Interfering with Amyloidosis. Blood. 2004; 104(12):3419-3420.
-
Skinner M, Seldin DC. . Amyloidosis. In: Lichtenstein LM, Busse WW, and Geha RS, ed. Current Therapy in Allergy, Immunology, and Rheumatology. Mosby. Philadelphia,PA. 2004; 260-7.
-
Oran B, Wright DG, Seldin DC, McAneny D, Skinner M, Sanchorawala V. Spontaneous rupture of the spleen in AL amyloidosis. Am J Hematol. 2003 Oct; 74(2):131-5.View Related Profiles. PMID: 14508801
-
Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003 Sep; 124(3):969-77.View Related Profiles. PMID: 12970025
-
Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol. 2003 Aug; 23(16):5738-54.View Related Profiles. PMID: 12897145; PMCID: PMC166341
-
Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int. 2003 May; 63(5):1868-73.View Related Profiles. PMID: 12675865
-
Song DH, Dominguez I, Mizuno J, Kaut M, Mohr SC, Seldin DC. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J Biol Chem. 2003 Jun 27; 278(26):24018-25.View Related Profiles. PMID: 12700239
-
Ramirez MI, Millien G, Hinds A, Cao Y, Seldin DC, Williams MC. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol. 2003 Apr 1; 256(1):61-72.View Related Profiles. PMID: 12654292
-
Seldin DC. Diagnosis and treatment of Al amyloidosis. Clin Adv Hematol Oncol. 2003 Mar; 1(3):154-5. PMID: 16224395
-
Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma. 2003 Mar; 3(4):241-6.View Related Profiles. PMID: 12672274
-
Casserly LF, Fadia A, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney Int. 2003 Mar; 63(3):1051-7.View Related Profiles. PMID: 12631087
-
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 2002 Nov 15; 62(22):6770-8.View Related Profiles. PMID: 12438279
-
Miller SJ, Lou DY, Seldin DC, Lane WS, Neel BG. Direct identification of PTEN phosphorylation sites. FEBS Lett. 2002 Sep 25; 528(1-3):145-53. PMID: 12297295
-
Seldin DC. AL amyloidosis, a curable disease? Amyloid. 2002 Sep; 9(3):203-6. PMID: 12408686
-
Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE, Cardiff RD. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol. 2002 Sep; 161(3):1087-97.View Related Profiles. PMID: 12213737; PMCID: PMC1867237
-
Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene. 2002 Aug 15; 21(36):5548-56.View Related Profiles. PMID: 12165853
-
Channavajhala P, Seldin DC. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene. 2002 Aug 8; 21(34):5280-8. PMID: 12149649
-
Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol. 2002 Jun; 117(4):886-9.View Related Profiles. PMID: 12060126
-
Shen J, Channavajhala P, Seldin DC, Sonenshein GE. Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha. J Immunol. 2001 Nov 1; 167(9):4919-25.View Related Profiles. PMID: 11673497
-
Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC. Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol Cell Biochem. 2001 Nov; 227(1-2):153-65.View Related Profiles. PMID: 11827167
-
Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001 Oct; 28(7):637-42.View Related Profiles. PMID: 11704785
-
Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene. 2001 May 31; 20(25):3247-57.View Related Profiles. PMID: 11423974
-
Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med. 2001 May 1; 134(9 Pt 1):746-53.View Related Profiles. PMID: 11329232
-
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res. 2001 May 1; 61(9):3810-8.View Related Profiles. PMID: 11325857
-
Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001 Mar 15; 97(6):1885-7.View Related Profiles. PMID: 11238135
-
Song DH, Sussman DJ, Seldin DC. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J Biol Chem. 2000 Aug 4; 275(31):23790-7. PMID: 10806215
-
Ford HL, Landesman-Bollag E, Dacwag CS, Stukenberg PT, Pardee AB, Seldin DC. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem. 2000 Jul 21; 275(29):22245-54.View Related Profiles. PMID: 10801845
-
Goldenberg DM, Abdel-Nabi H, Sullivan CL, Serafini A, Seldin D, Barron B, Lamki L, Line B, Wegener WA. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma. Cancer. 2000 Jul 1; 89(1):104-15. PMID: 10897007
-
Xu X, Toselli PA, Russell LD, Seldin DC. Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat Genet. 1999 Sep; 23(1):118-21.View Related Profiles. PMID: 10471512
-
Xu X, Landesman-Bollag E, Channavajhala PL, Seldin DC. Murine protein kinase CK2: gene and oncogene. Mol Cell Biochem. 1999 Jan; 191(1-2):65-74.View Related Profiles. PMID: 10094394
-
Rifkin IR, Channavajhala PL, Kiefer HL, Carmack AJ, Landesman-Bollag E, Beaudette BC, Jersky B, Salant DJ, Ju ST, Marshak-Rothstein A, Seldin DC. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. J Immunol. 1998 Nov 15; 161(10):5164-70.View Related Profiles. PMID: 9820486
-
Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene. 1998 Jun 11; 16(23):2965-74.View Related Profiles. PMID: 9662328
-
Wang F, Seldin DC, Annis B, Trocha A, Johnson RP. Immune modulation of human B lymphocytes by gene transfer with recombinant Epstein-Barr virus amplicons. J Virol Methods. 1998 May; 72(1):81-93. PMID: 9672135
-
Xu X, Rich ES, Seldin DC. Murine protein kinase CK2 alpha': cDNA and genomic cloning and chromosomal mapping. Genomics. 1998 Feb 15; 48(1):79-86. PMID: 9503019
-
Kelliher MA, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 1996 Oct 1; 15(19):5160-6. PMID: 8895560; PMCID: PMC452259
-
Wasik MA, Seldin DC, Butmarc JR, Gertz R, Marti R, Maslinski W, Kadin ME. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. Leuk Lymphoma. 1996 Sep; 23(1-2):125-36.View Related Profiles. PMID: 9021695
-
Seldin DC. New models of lymphoma in transgenic mice. Curr Opin Immunol. 1995 Oct; 7(5):665-73. PMID: 8573310
-
Seldin DC, Leder P. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science. 1995 Feb 10; 267(5199):894-7. PMID: 7846532
-
Seldin DC, Leder P. Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proc Natl Acad Sci U S A. 1994 Mar 15; 91(6):2140-4. PMID: 8134361; PMCID: PMC43325
-
Skoda RC, Seldin DC, Chiang MK, Peichel CL, Vogt TF, Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 1993 Jul; 12(7):2645-53. PMID: 8334987; PMCID: PMC413511
-
Seldin DC, Austen KF . Mast cell subclasses and their growth dependence in mice, rats, and humans. In: Schrader JW, ed. Multilineage growth factor (IL-3). Lymphokines. Academic Press. New York,NY. 1988; 15:313-40.
-
Stevens RL, Lee TD, Seldin DC, Austen KF, Befus AD, Bienenstock J. Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans. J Immunol. 1986 Jul 1; 137(1):291-5. PMID: 3086452
-
Seldin DC, Caulfield JP, Hein A, Osathanondh R, Nabel G, Schlossman SF, Stevens RL, Austen KF. Biochemical and phenotypic characterization of human basophilic cells derived from dispersed fetal liver with murine T cell factors. J Immunol. 1986 Mar 15; 136(6):2222-30. PMID: 2419426
-
Stevens RL, Katz HK, Seldin DC, Austen KF. . Biochemical characteristics distinguish subclasses of mammalian mast cells. In: Befus AD, Bienenstock J, Denburg JA, eds. Mast cell differentiation and homogeneity. Raven Press. New York,NY. 1986; 183-203.
-
Robin JL, Seldin DC, Austen KF, Lewis RA. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J Immunol. 1985 Oct; 135(4):2719-26. PMID: 3161947
-
Seldin DC, Austen KF, Stevens RL. Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells. J Biol Chem. 1985 Sep 15; 260(20):11131-9. PMID: 2411730
-
Seldin DC, Adelman S, Austen KF, Stevens RL, Hein A, Caulfield JP, Woodbury RG. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc Natl Acad Sci U S A. 1985 Jun; 82(11):3871-5. PMID: 3923482; PMCID: PMC397890
-
Seldin DC, Austen KF . Mast cell-T cell interactions. In: Sehon AH, ed. IgE antibodies: their synthesis and effector functions. Pharmacia AB. Uppsala, Sweden. 1985; 75-95.
-
Seldin DC, Austen KF . Mast cell heterogeneity: the T cell factor-dependent mast cell in vitro and in vivo. In: Greaves MW, Black AK, Pye RJ, Champion RH. The urticarias. Churchill Livingstone. Cambridge, England. 1985; 12-25.
-
Stevens RL, Bloes WF, Seldin DC, Razin E, Katz HR, Austen KF. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype. J Immunol. 1984 Nov; 133(5):2674-80. PMID: 6332858
-
Seldin DC, Seno N, Austen KF, Stevens RL. Analysis of polysulfated chondroitin disaccharides by high-performance liquid chromatography. Anal Biochem. 1984 Aug 15; 141(1):291-300. PMID: 6437272
-
Razin E, Ihle JN, Seldin D, Mencia-Huerta JM, Katz HR, LeBlanc PA, Hein A, Caulfield JP, Austen KF, Stevens RL. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol. 1984 Mar; 132(3):1479-86. PMID: 6198393
-
Pinkus GS, Maier M, Seldin DC, ole-MoiYoi OK, Austen KF, Spragg J. Immunohistochemical localization of glandular kallikrein in the endocrine and exocrine human pancreas. J Histochem Cytochem. 1983 Nov; 31(11):1279-88. PMID: 6194204
-
ole-MoiYoi O, Seldin DC, Pinkus GS . Human kidney and pancreatic glandular kallikreins: structure, immunohistochemical localization, and functional characteristics. In: McConn R, ed. The role of chemical mediators in the pathophysiology of acute illness and injury. Raven Press. New York,NY. 1982; 271-89.
-
Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol. 1981 Apr; 126(4):1290-4. PMID: 7009736
-
ole-MoiYoi O, Pinkus GS, Seldin DC, Spragg J, Austen KF . Structure, functional characteristics and immunohistochemical localization of human glandular kallikreins from kidney and pancreas. In: Bing DH, Rosenbaum RA, eds. Plasma and cellular modulatory proteins. Boston: Center for Blood Research. 1981; 183-201.
-
Yoi OO, Seldin DC, Spragg J, Pinkus GS, Austen KF. Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):3612-6. PMID: 386342; PMCID: PMC383882
-
Seldin DC . The Future of Molecular Diagnostics and Targeted Therapeutics in the Amyloidoses. In: Sipe J, ed. Amyloid Proteins: The Beta Pleated Sheet Conformation and Disease, chapter 15. Wiley-VCH. 343-354.